Last reviewed · How we verify
Menstridyl (chlormadinone)
Menstridyl (generic name: chlormadinone) is a drug. It is currently in unknown development for Endometriosis, Menorrhagia.
Menstridyl works by blocking the action of cortisol, a hormone involved in the menstrual cycle.
Menstridyl (chlormadinone) is a small molecule modality targeting the glucocorticoid receptor. It is used to treat endometriosis and menorrhagia, but its commercial status and FDA approval status are unknown. As a glucocorticoid receptor antagonist, Menstridyl works by blocking the action of cortisol, a hormone involved in the regulation of the menstrual cycle. This can help reduce symptoms associated with endometriosis and menorrhagia. However, more information is needed to fully understand its pharmacological properties and clinical applications.
At a glance
| Generic name | chlormadinone |
|---|---|
| Target | Glucocorticoid receptor |
| Therapeutic area | Pain |
| Phase | unknown |
Mechanism of action
Think of cortisol like a key that unlocks certain processes in the body. Menstridyl is like a lock that blocks that key, preventing cortisol from triggering certain responses in the body. This can help reduce symptoms like heavy bleeding and pain associated with endometriosis and menorrhagia.
Approved indications
- Endometriosis
- Menorrhagia
Common side effects
- Meningioma
- Ulnar tunnel syndrome
- Diabetic metabolic decompensation
Key clinical trials
- RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism
- Comparison of Body Weight Change During Contraception With Belara and Yasmin (PHASE4)
- Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile (PHASE4)
- Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Menstridyl CI brief — competitive landscape report
- Menstridyl updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Menstridyl
What is Menstridyl?
How does Menstridyl work?
What is Menstridyl used for?
What is the generic name of Menstridyl?
What development phase is Menstridyl in?
What are the side effects of Menstridyl?
What does Menstridyl target?
Related
- Target: All drugs targeting Glucocorticoid receptor
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Pain
- Indication: Drugs for Endometriosis
- Indication: Drugs for Menorrhagia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing